Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03368118
Recruitment Status : Active, not recruiting
First Posted : December 11, 2017
Last Update Posted : March 31, 2022
Orion Corporation, Orion Pharma
Information provided by (Responsible Party):
Abivax S.A.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : March 8, 2019
Estimated Study Completion Date : October 2022